It's starting to feel a little like "Let's Make a Deal."
The price tag? The takeover bid comes in at a cool $63 billion.
Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015. Read Real Money's take here.
It's just the latest in a long string of deals for 2019.
Watch the video for an M&A round-up.